Volume dana dhuwit perusahaan MannKind (MNKD)

Tandha merek mannkindcorp.com (MNKD)

MannKind Corporation occupies a unique niche by developing painless inhalable insulin delivery systems. The company's cash history demonstrates financial resilience, while 0.10 records a new level mark. The business relies on external distribution coupled with in-house production, and stable royalty payments for hypertension medications provide a liquidity inflow that supports current development.

Dhuwit awis lan setara dhuwit awis perusahaan: MannKind Corp (MNKD) kanggo 04.07.2022 - 21.11.2026

Rincian metrik keuangan lan pasar MannKind (MNKD)

- nilai saham lan prakiraan konsensus rega:
Analisis fundamental perusahaan:MNKD MannKind Corp
Sampel barang mannkindcorp.com

Total cash holdings determine the company's liquid safety margin, allowing for an assessment of its resilience to macroeconomic shocks. By analyzing the cash flow chart, an investor can see the balance between financial protection and the risk of inflationary asset depreciation, which is critical for MannKind Corporation (MNKD) when monetizing patents for its unique inhaled insulin and implementing a premium pricing strategy.

Pesaing MannKind Corporation (MNKD)

Dana dhuwit perusahaan Haleon (HLN)|Volume dana dhuwit perusahaan Kenvue Inc. (KVUE)|Volume dana dhuwit perusahaan VRNA (veronapharma.com)|Sisa dhuwit perusahaan MENS|LGND: Dhuwit awis perusahaan|Sisa dhuwit perusahaan AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Dhuwit awis perusahaan|Alvotech - Sisa dhuwit perusahaan|Dhuwit awis perusahaan LQDA|Galapagos Genomics (GLPG) - Aset likuid perusahaan|Volume dana dhuwit perusahaan ANIP|AMPH (Amphastar Corp) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan pacira.com PCRX|SPRY - Dhuwit awis perusahaan|Theravance Biopharma, Inc. - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AQST (Aquestive Therapeutics, Inc.)|SCPH: Volume dana dhuwit perusahaan|Tectonic Therapeutic Inc. - Sisa dhuwit perusahaan|TNXP (Tonix Pharma) - Volume dana dhuwit perusahaan|SXTC: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan EPRX|BHST - Cadangan dhuwit perusahaan|eXoZymes - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan oramed.com ORMP|ENTX - Dana dhuwit perusahaan|Aset likuid perusahaan MindWalk Holdings HYFT|ABVC: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Cumberland Pharmaceuticals Inc.|Dana dhuwit perusahaan Quantum BioPharma Limited|FGEN: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan TELO|Rani Therapeutics Holdings, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Synergy CHC Corp. SNYR|Sisa dhuwit perusahaan RLYB|LEXX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Aptorum|Dhuwit awis perusahaan LYRA|Impact BioMedical Inc - Total volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan TNFA|YCBD - Cadangan dhuwit perusahaan|PainReform Ltd. - Dhuwit awis perusahaan|CYTO (Auris Medical) - Total volume dana dhuwit perusahaan|LIPO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan OPTN (OptiNose)|PIRS: Volume dana dhuwit perusahaan|Procaps Group S.A. (PROC) - Volume dana dhuwit perusahaan|PTPI (Petros Pharma) - Volume dana dhuwit perusahaan|QLI: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SLRN|TFFP (TFF Pharmaceuticals Inc.) - Sisa dhuwit perusahaan